Ciprofloxacin lactate

Base Information

• Chemical Name: Ciprofloxacin lactate
• CAS No.: 97867-33-9
• Molecular Formula: C17H18FN3O3^.C3H6O3
• Molecular Weight: 421.43
• Hs Code.: 29339900
• European Community (EC) Number: 809-928-8
• UNII: UEY6XFC224
• DSSTox Substance ID: DTXSID20913608
• Wikidata: Q27291047
• ChEMBL ID: CHEMBL1077975
• Mol file: 97867-33-9.mol

Synonyms:Ciprofloxacin lactate;97867-33-9;Flunase [inj.];Cipobacter;1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid compound with 2-hydroxypropanoic acid (1:1);Ificipro;Ciproxin [inj.];Quintor Eye Drops;Ciproflox [inj.];Ciproxina [inj.];Flociprin [inj.];Ciprobid Eye Drops;Ciproxin;Flociprin;Ciprofloxacin (lactate);857213-31-1;UNII-UEY6XFC224;UEY6XFC224;1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid;96186-80-0;3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, mono(2-hydroxypropanoate);Ciproxin (TN);CIPROFLOXACIN LACTAT;SCHEMBL667608;CHEMBL1077975;C20H24FN3O6;DTXSID20913608;CIPROFLOXACIN (AS LACTATE);C17H18FN3O3.C3H6O3;(+/-)-CIPROFLOXACIN LACTATE;MFCD01759747;CIPROFLOXACIN LACTATE [MART.];AKOS015896304;CIPROFLOXACIN LACTATE [WHO-DD];CS-W021038;HY-W040298;CIPROFLOXACIN LACTATE, (+/-)-;1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid;DS-11431;LS-141565;FT-0602944;C17-H18-F-N3-O3.C3-H6-O3;D07702;D82460;A845757;Q27291047;alpha-?hydroxy-?4-?methoxy-?alpha-?(2-?oxopropyl)?-Benzenebutanoic acid? hydrate (1:1);1-CycloPr-6-fluoro-4-oxo-7-(piperaZin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid comp with 2-hydroxypropanoic acid(1:1);95%;1-cyclopropyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-quinoline-3-carboxylic acid;2-oxidanylpropanoic acid;1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-Quinolinecarboxylic Acid Mono(2-hydroxypropanoate);1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid;1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid 2-hydroxypropanoic acid salt;1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid--2-hydroxypropanoic acid (1/1);1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacidcompoundwith2-hydroxypropanoicacid(1:1);1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,2-hydroxypropanoic acid;3-QUINOLINECARBOXYLIC ACID, 1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)-, 2-HYDROXYPROPANOATE (1:1)

Chemical Property of Ciprofloxacin lactate

Chemical Property:

• Appearance/Colour: powder
• Vapor Pressure: 2.24E-14mmHg at 25°C
• Melting Point: 255-257 °C
• Boiling Point: 581.8 °C at 760 mmHg
• Flash Point: 305.6 °C
• PSA: 100.87000
• LogP: 1.34310
• Storage Temp.: Inert atmosphere,Room Temperature
• Solubility.: DMSO (Slightly), Methanol (Slightly, Heated)
• Hydrogen Bond Donor Count: 4
• Hydrogen Bond Acceptor Count: 10
• Rotatable Bond Count: 4
• Exact Mass: 421.16491366
• Heavy Atom Count: 30
• Complexity: 631

Purity/Quality:

99% ^*data from raw suppliers

CiprofloxacinLactate ^*data from reagent suppliers

Safty Information:

• Safety Statements: 24/25

MSDS Files:

SDS file from LookChem

Useful:

• Canonical SMILES: CC(C(=O)O)O.C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
• Recent ClinicalTrials: Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition
• Recent EU Clinical Trials: A Multicentre Randomised Control Trial Assessing the Efficacy of Antimicrobial Prophylaxis for Extracorporeal Shock Wave Lithotripsy on reducing Urinary Tract Infections
• Uses: Ciprofloxacin Lactate is an antibiotic that has been used to medicate polymer wound dressing. Ciprofloxacin Lactate has been shown to produce high and sustained serum bactericidal titers against highly susceptible bacteria.